Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)

[Abstract] Aims. There is little information on the familial nature of dyslipidemias in the Spanish population. This knowledge could have potential diagnostic and treatment implications. The objective of the GALIPEMIAS study was to determine the prevalence of familial dyslipidemia in Galicia, as well as determine the degree of lipid control in the participants. Prevalence of atherosclerotic cardiovascular disease (ASCVD) was also estimated. This paper presents the design, methodology and selected preliminary results. Methodology. A cross‐sectional study was performed in the population aged ≥18 years using cluster sampling and then random sampling. A sample of 1000 subjects was calculated and divided into three sequential phases with a specific methodology for each one. Phase I: selection of subjects from the general population and collection of informed consent documents; Phase II: collection of data from the digital clinical history to select subjects with dyslipidemia according to study criteria; Phase III: personal interview, blood analysis, family tree, and definitive diagnosis of dyslipidemia. Prevalence of different diseases and active medication was analysed. Corrected prevalence (to the reference population) of different risk factors and ASCVD was estimated. Results. Phase I participation was 89.5%. We extracted complete information from 93% of the participants (Phase II). According to the study′s own criteria, 56.5% (n = 527) of the participants had some form of dyslipidemia and almost 33.7% of them had familial dyslipidemia with autosomal dominant inherit pattern. The corrected prevalence of ASCVD was 5.1% (95% CI 3.1‐7.2). Conclusions. Dyslipidemia was the most prevalent cardiovascular risk factor in our population with an autosomal dominant inheritance pattern in one out of every three dyslipidemia cases. Approximately, 5.1% of the sample population aged ≥18 has suffered an episode of ACVD

Enfermedad pulmonar intersticial y crepitantes. Algunas reflexiones sobre sus características y localización

Enfermedad pulmonar intersticial y crepitantes. Algunas reflexiones sobre sus características y localizació

Síndrome de distress respiratorio agudo asociado a eritrodermia psoriásica

El síndrome del distress respiratorio agudo (SDRA) es una complicación severa que se ha asociado de manera excepcional a psoriasis pustular generalizado (PPG) y a eritrodermia psoriásica (EP)1,2. El conocimiento de esta entidad es muy importante ya que si no se trata precozmente con dosis altas de corticoides tiene una alta mortalidad. Describimos a continuación un paciente que desarrolló un SDRA asociado a EP

Síndrome de distress respiratorio agudo asociado a eritrodermia psoriásica

Resumen: El síndrome del distress respiratorio agudo es una complicación severa que se ha asociado de manera excepcional a psoriasis pustular generalizado y a eritrodermia psoriásica. Se debe sospechar esta entidad ante la presencia de fiebre y un deterioro respiratorio rápido en un paciente con una de estas formas graves de psoriasis. El conocimiento de esta patología es muy importante ya que si no se trata precozmente con dosis altas de corticoides tiene una alta mortalidad. Abstract: Acute respiratory distress syndrome is a severe and rare complication of generalized pustular psoriasis and erythrodermic psoriasis. This entity should be suspected when a patient with one of these severe forms of psoriasis presents with high fever and worsening respiratory fast. Knowledge of this pathology is crucial because has high mortality without treatment with high doses of corticosteroids